BRAIN Biotech AG (BNN.DE)
EUR 2.38
(0.42%)
EUR 2.38
(0.42%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 55.33 Million EUR | 11.77% |
| 2022 | 49.5 Million EUR | 28.97% |
| 2021 | 38.38 Million EUR | 0.43% |
| 2020 | 38.22 Million EUR | -0.87% |
| 2019 | 38.56 Million EUR | 42.55% |
| 2018 | 27.05 Million EUR | 12.22% |
| 2017 | 24.1 Million EUR | 5.77% |
| 2016 | 22.78 Million EUR | 7.84% |
| 2015 | 21.13 Million EUR | 62.71% |
| 2014 | 12.98 Million EUR | 28.15% |
| 2013 | 10.13 Million EUR | 35.56% |
| 2012 | 7.47 Million EUR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 13.19 Million EUR | -51.51% |
| 2024 Q1 | 12.72 Million EUR | -14.81% |
| 2024 Q2 | 27.2 Million EUR | 113.72% |
| 2023 Q1 | 13.69 Million EUR | 1.17% |
| 2023 Q4 | 14.94 Million EUR | 13.0% |
| 2023 FY | 55.33 Million EUR | 11.77% |
| 2023 Q3 | 13.22 Million EUR | -1.88% |
| 2023 Q2 | 13.47 Million EUR | -1.59% |
| 2022 Q2 | 13.09 Million EUR | 28.62% |
| 2022 FY | 49.5 Million EUR | 28.97% |
| 2022 Q4 | 13.53 Million EUR | 6.52% |
| 2022 Q3 | 12.7 Million EUR | -2.93% |
| 2022 Q1 | 10.17 Million EUR | -3.48% |
| 2021 Q1 | 8.07 Million EUR | -6.84% |
| 2021 FY | 38.38 Million EUR | 0.43% |
| 2021 Q2 | 9.92 Million EUR | 22.84% |
| 2021 Q4 | 10.54 Million EUR | 7.11% |
| 2021 Q3 | 9.84 Million EUR | -0.8% |
| 2020 Q4 | 8.67 Million EUR | -9.91% |
| 2020 Q1 | 10.32 Million EUR | -2.85% |
| 2020 Q3 | 9.62 Million EUR | 0.19% |
| 2020 Q2 | 9.6 Million EUR | -6.94% |
| 2020 FY | 38.22 Million EUR | -0.87% |
| 2019 FY | 38.56 Million EUR | 42.55% |
| 2019 Q4 | 10.62 Million EUR | 12.86% |
| 2019 Q3 | 9.41 Million EUR | 3.7% |
| 2019 Q1 | 9.44 Million EUR | 5.97% |
| 2019 Q2 | 9.07 Million EUR | -3.82% |
| 2018 Q2 | 5.42 Million EUR | 2.63% |
| 2018 FY | 27.05 Million EUR | 12.22% |
| 2018 Q4 | 8.9 Million EUR | 19.78% |
| 2018 Q3 | 7.43 Million EUR | 37.16% |
| 2018 Q1 | 5.28 Million EUR | -14.72% |
| 2017 Q3 | 5.79 Million EUR | -4.15% |
| 2017 Q1 | 6.07 Million EUR | -2.97% |
| 2017 Q2 | 6.04 Million EUR | -0.63% |
| 2017 FY | 24.1 Million EUR | 5.77% |
| 2017 Q4 | 6.19 Million EUR | 6.99% |
| 2016 Q4 | 6.26 Million EUR | 16.79% |
| 2016 FY | 22.78 Million EUR | 7.84% |
| 2016 Q3 | 5.36 Million EUR | 4.93% |
| 2016 Q2 | 5.11 Million EUR | -15.46% |
| 2016 Q1 | 6.04 Million EUR | 19.09% |
| 2015 Q1 | 5.63 Million EUR | 0.0% |
| 2015 FY | 21.13 Million EUR | 62.71% |
| 2015 Q2 | 5.3 Million EUR | -5.83% |
| 2015 Q3 | 5.12 Million EUR | -3.45% |
| 2015 Q4 | 5.07 Million EUR | -0.82% |
| 2014 FY | 12.98 Million EUR | 28.15% |
| 2013 FY | 10.13 Million EUR | 35.56% |
| 2012 FY | 7.47 Million EUR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| BioNTech SE | 3.81 Billion EUR | 98.551% |
| CureVac N.V. | 53.75 Million EUR | -2.934% |
| Biotest Aktiengesellschaft | 684.6 Million EUR | 91.917% |
| Biotest Aktiengesellschaft | 684.6 Million EUR | 91.917% |
| Formycon AG | 77.69 Million EUR | 28.78% |
| Heidelberg Pharma AG | 9.85 Million EUR | -461.269% |
| Medigene AG | 6.03 Million EUR | -817.053% |